138 related articles for article (PubMed ID: 10560909)
41. Multiple myeloma: relationship between light chain isotype suppression, labelling index of plasma cells, and CD38 expression on peripheral blood lymphocytes.
Joshua DE; Ioannidis R; Brown R; Francis SE; Gibson J; Kronenberg H
Am J Hematol; 1988 Sep; 29(1):5-11. PubMed ID: 3052044
[TBL] [Abstract][Full Text] [Related]
42. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.
Liu Z; Cumberland WG; Hultin LE; Prince HE; Detels R; Giorgi JV
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Oct; 16(2):83-92. PubMed ID: 9358102
[TBL] [Abstract][Full Text] [Related]
43. Expression of Flt3 and c-kit during growth and maturation of human CD34+CD38- cells.
Xiao M; Oppenlander BK; Plunkett JM; Dooley DC
Exp Hematol; 1999 May; 27(5):916-27. PubMed ID: 10340408
[TBL] [Abstract][Full Text] [Related]
44. Preliminary studies for an immunotherapeutic approach to the treatment of human myeloma using chimeric anti-CD38 antibody.
Stevenson FK; Bell AJ; Cusack R; Hamblin TJ; Slade CJ; Spellerberg MB; Stevenson GT
Blood; 1991 Mar; 77(5):1071-9. PubMed ID: 1995092
[TBL] [Abstract][Full Text] [Related]
45. Erythropoietin receptor expression on human bone marrow erythroid precursor cells by a newly-devised quantitative flow-cytometric assay.
Shinjo K; Takeshita A; Higuchi M; Ohnishi K; Ohno R
Br J Haematol; 1997 Mar; 96(3):551-8. PubMed ID: 9054663
[TBL] [Abstract][Full Text] [Related]
46. CD38/ADP-ribosyl cyclase: A new role in the regulation of osteoclastic bone resorption.
Sun L; Adebanjo OA; Moonga BS; Corisdeo S; Anandatheerthavarada HK; Biswas G; Arakawa T; Hakeda Y; Koval A; Sodam B; Bevis PJ; Moser AJ; Lai FA; Epstein S; Troen BR; Kumegawa M; Zaidi M
J Cell Biol; 1999 Sep; 146(5):1161-72. PubMed ID: 10477767
[TBL] [Abstract][Full Text] [Related]
47. Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia.
Heintel D; Schwarzinger I; Chizzali-Bonfadin C; Thalhammer R; Schwarzmeier J; Fritzer-Szekeres M; Weltermann A; Simonitsch I; Lechner K; Jaeger U
Leuk Lymphoma; 2001; 42(6):1315-21. PubMed ID: 11911414
[TBL] [Abstract][Full Text] [Related]
48. All-trans-retinoic acid up-regulates CD38 but not c-Kit antigens on human marrow CD34+ cells without recruitment into cell cycle.
Herault O; Domenech J; Degenne M; Bremond JL; Sensebe L; Bernard MC; Binet C; Colombat P
Br J Haematol; 1998 Nov; 103(2):343-50. PubMed ID: 9827903
[TBL] [Abstract][Full Text] [Related]
49. Soluble urokinase-type plasminogen activator receptor (suPAR) as an independent factor predicting worse prognosis and extra-bone marrow involvement in multiple myeloma patients.
Rigolin GM; Tieghi A; Ciccone M; Bragotti LZ; Cavazzini F; Della Porta M; Castagnari B; Carroccia R; Guerra G; Cuneo A; Castoldi G
Br J Haematol; 2003 Mar; 120(6):953-9. PubMed ID: 12648064
[TBL] [Abstract][Full Text] [Related]
50. In multiple myeloma clonotypic CD38- /CD19+ / CD27+ memory B cells recirculate through bone marrow, peripheral blood and lymph nodes.
Rasmussen T; Lodahl M; Hancke S; Johnsen HE
Leuk Lymphoma; 2004 Jul; 45(7):1413-7. PubMed ID: 15359642
[TBL] [Abstract][Full Text] [Related]
51. A novel multiparametric approach for analysis of cytoplasmic immunoglobulin light chains by flow cytometry.
Chang CC; Schur BC; Kampalath B; Lindholm P; Becker CG; Vesole DH
Mod Pathol; 2001 Oct; 14(10):1015-21. PubMed ID: 11598172
[TBL] [Abstract][Full Text] [Related]
52. Detection of myeloma cells in the peripheral blood by flow cytometry.
Witzig TE; Kimlinger TK; Ahmann GJ; Katzmann JA; Greipp PR
Cytometry; 1996 Jun; 26(2):113-20. PubMed ID: 8817086
[TBL] [Abstract][Full Text] [Related]
53. Establishment of serum-free pre-colony forming unit assays for differentiation of primitive hematopoietic progenitors: serum induces early macrophage differentiation and inhibits early erythroid differentiation of CD34++CD38- cells.
Willems R; Henckaerts E; Lenjou M; Nijs G; Rodrigus I; Moulijn AC; Slegers H; Berneman ZN; Van Bockstaele DR
Ann Hematol; 2001 Jan; 80(1):17-25. PubMed ID: 11233770
[TBL] [Abstract][Full Text] [Related]
54. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.
Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P
Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217
[TBL] [Abstract][Full Text] [Related]
55. Myeloid-lymphoid initiating cells (ML-IC) are highly enriched in the rhodamine-c-kit(+)CD33(-)CD38(-) fraction of umbilical cord CD34(+) cells.
Liu H; Verfaillie CM
Exp Hematol; 2002 Jun; 30(6):582-9. PubMed ID: 12063025
[TBL] [Abstract][Full Text] [Related]
56. Differences in cell cycle kinetics of candidate engrafting cells in human bone marrow and mobilized peripheral blood.
Thornley I; Nayar R; Freedman MH; Stephens D; Crump M; Messner HA; Sutherland DR
Exp Hematol; 2001 Apr; 29(4):525-33. PubMed ID: 11301193
[TBL] [Abstract][Full Text] [Related]
57. C-kit receptor (CD117) expression on plasma cells in monoclonal gammopathies.
Kraj M; Pogłód R; Kopeć-Szlezak J; Sokołowska U; Woźniak J; Kruk B
Leuk Lymphoma; 2004 Nov; 45(11):2281-9. PubMed ID: 15512818
[TBL] [Abstract][Full Text] [Related]
58. ADP-Ribosyl cyclase in rat vascular smooth muscle cells: properties and regulation.
de Toledo FG; Cheng J; Liang M; Chini EN; Dousa TP
Circ Res; 2000 Jun; 86(11):1153-9. PubMed ID: 10850967
[TBL] [Abstract][Full Text] [Related]
59. Transforming growth factor-beta(1) induces apoptosis in CD34(+)CD38(-/low) cells that express Bcl-2 at a low level.
Xiao M; Oppenlander BK; Dooley DC
Exp Hematol; 2001 Sep; 29(9):1098-108. PubMed ID: 11532351
[TBL] [Abstract][Full Text] [Related]
60. [Immunophenotypic characteristics of multiple myeloma cells].
Li JL; Liu YR; Chang Y; Fu JY; Chen SS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):226-8. PubMed ID: 12513791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
